Vincent Jongkind,Max Hoebink/LinkedIn
Mar 30, 2026, 17:35
Vincent Jongkind: Everything You Need to Know on The Use of Anti-Xa During Arterial Procedures
Vincent Jongkind, Vascular Surgeon at Amsterdam UMC and Treasurer of European Society for Vascular Surgery, shared on LinkedIn about a recent article he and his colleagues co-authored, adding:
”Max Hoebink and team have written a systematic review on the use of anti-Xa during arterial procedures in Journal of Thrombosis and Haemostasis (JTH).
Everything you need to know.”
Title: Clinical applicability of anti-Xa measurements to monitor unfractionated heparin activity during arterial procedures: a scoping review
Authors: Max Hoebink, Thomas Steunenberg, Sjoerd Smit, Henrike Hamer, Arno Wiersema, Kak Khee Yeung, Vincent Jongkind
Read the Full Article on JTH
Stay updated on all scientific advances with Hemostasis Today.
-
Mar 30, 2026, 17:29Shazmah Shaikh: Stroke Care Is Not Just Treatment – It’s Timing, Precision, and Strategy
-
Mar 30, 2026, 17:28Rita Ferdinardo: Am I Too Young To Have a Stroke?
-
Mar 30, 2026, 17:27MAPTO Survey Reveals Global Variability in Managing FVIII Inhibitors in Children on Emicizumab – JTH
-
Mar 30, 2026, 17:26Asif Dogar: Diagnostic Clues and Radiological Patterns of Cerebral Venous Thrombosis In a Coming Webinar
-
Mar 30, 2026, 17:25Maria Angelica Pabon: LPA Relation to VTE Appears To Be Hormone-Dependent
-
Mar 30, 2026, 17:21Joyisa Deb: Does Parenteral Iron Increase Infection Risk?
-
Mar 30, 2026, 17:02Phil Choi: 50 Times a Life Saver
-
Mar 30, 2026, 15:49Archil Jaliashvili: How Patients and Care Partners Navigate Chronic Illness and Transplant Medicine
-
Mar 30, 2026, 15:47Omar Adwan: Clinical and Laboratory Features of Megaloblastic Anemia